Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Phil

Biotech & Life Sciences · San Francisco, United States · Founded 2015

Phil.us is a healthcare technology startup that aims to revolutionize the way patients access their medications. The company operates in the healthcare and pharmaceutical markets, serving both healthcare providers (HCPs) and patients. Its primary offering is the PhilRx platform, a digital tool designed to streamline the process of obtaining prescribed medications. The platform's main features include a national dispense network, real-time HIPAA compliant data, and actionable insights. It simplifies the prior authorization process, ensuring that patients can start their therapy without delay. By negotiating formulary access, Phil.us guarantees that prescriptions are covered by insurance, reducing the financial burden on patients. The company's business model is centered around improving patient adherence to medication regimens and increasing the number of prescriptions covered by insurance. This is achieved by removing barriers to medication access and providing a seamless experience for both patients and healthcare providers. Phil.us also offers consulting services to help healthcare providers optimize their channel strategies and build effective telemedicine programs. These services aim to improve patient access and drive transformative brand outcomes. In terms of revenue generation, Phil.us likely makes money through a combination of platform subscription fees from healthcare providers, consultation fees, and possibly a percentage from each prescription filled through their platform. In conclusion, Phil.us is a promising startup that leverages technology to simplify medication access and improve patient outcomes in the healthcare sector. Keywords: Healthcare Technology, Patient Access, Medication Adherence, Prescription Coverage, Prior Authorization, Telemedicine, Consulting Services, HIPAA Compliant Data, Pharmaceutical Market, National Dispense Network.

Valuation
$100–500M
Latest valuation · 2021
Unlock exact value
Headcount
100–500
Current team size
Unlock exact value
Total funding Pre-IPO
$50–100M
Unlock exact value

Investors

16 investors on Phil's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 9 investors entered at this stage
Series A 5 investors entered at this stage
Crosslink Capital
Silicon Valley Bank
Transmedia Capital
GreatPoint Ventures
Tarsadia Investments
Series B+ 2 investors entered at this stage
Warburg Pincus
K2 HealthVentures

Global footprint

Where Phil has talent and traffic

Workforce by country
9 countries with
team presence
🇺🇸 United States93.2%
🇵🇭 Philippines1.9%
🇮🇳 India1.2%
🇨🇦 Canada0.6%
🇲🇽 Mexico0.6%
Top 5 of 9 shown

Talent graph

The shape of Phil's talent

Dealroom maps Phil's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

21 team members profilednamed & role-tagged by Dealroom
284 employeestotal headcount
4 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Phil's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Phil

An AI-synthesized read of the highest-engagement posts about Phil on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Phil on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.